Sodium fusidate in Gillain-Barré syndrome: A case report

Journal of Neurology Neurosurgery and Psychiatry

Volumn 65, Issue 2, 1998, Pages 266-268

  Nicoletti, Ferdinando ^a,e   Nicoletti, Alessandra ^b   Giuffrida, Salvatore ^b   Di Marco, Roberto ^b   Meroni, PierLuigi ^c   Bendtzen, Klaus ^d   Lunetta, Michele ^b  

^a UNIVERSITY OF MILAN   (Italy)

^b UNIVERSITY OF CATANIA   (Italy)

^c FONDAZIONE IRCCS POLICLINICO SAN MATTEO   (Italy)

^d University of Copenhagen   (Denmark)

^e NONE   (Italy)

Author keywords

Autoimmunity; Cytokines; Fucidin; Guillian Barr syndrome

Indexed keywords

CYTOKINE; FUSIDATE SODIUM; GAMMA INTERFERON; IMMUNOSUPPRESSIVE AGENT; INTERLEUKIN 2; TUMOR NECROSIS FACTOR ALPHA;

ADULT; ARTICLE; BLOOD LEVEL; CASE REPORT; CYTOKINE PRODUCTION; DRUG TOLERABILITY; FEMALE; GUILLAIN BARRE SYNDROME; HUMAN; IMMUNOSUPPRESSIVE TREATMENT; ORAL DRUG ADMINISTRATION; PRIORITY JOURNAL;

DOSE-RESPONSE RELATIONSHIP, DRUG; DRUG ADMINISTRATION SCHEDULE; FEMALE; FUSIDIC ACID; HUMANS; IMMUNOSUPPRESSIVE AGENTS; INTERFERON TYPE II; INTERLEUKIN-2; MIDDLE AGED; NEUROLOGIC EXAMINATION; POLYRADICULONEUROPATHY; TUMOR NECROSIS FACTOR-ALPHA;

EID: 0031824966     PISSN: 00223050     EISSN: None     Source Type: Journal    
DOI: 10.1136/jnnp.65.2.266     Document Type: Article

References (19)

1. Ropper AH. The Guillain-Barré syndrome. N Engl J Med 1992;326:1130-6.
2. Rostami AM. Guillain-Barré syndrome: clinical and immunological aspects. Springer Semin Immunopathol 1995;17: 29-42.
3. Nicoletti F, Meroni PL, Bendtzen K. Fusidic acid and insulin-dependent diabetes mellitus. Autoimmunity 1996; 24:187-97.
4. Peter JB, Boctor FN, Tourtellotte WW. Serum and CSF levels of IL-2, sIL-2R, TNF-α, and IL-1β in chronic progressive multiple sclerosis: expected lack of clinical utility. Neurology 1991;41:121-3.
5. Nicoletti F, Scalia G, Condorelli F, et al. Anti-cytomegalovirus IgM and IgG antibodies, islet cell antibodies and γ interferon serum levels in newly diagnosed IDDM patients. Int J Immunopathol Immunopharmacol 1991;4:99-106.
6. Asbury AK. Diagnostic considerations in Guillain-Barré syndrome. Ann Neurol 1981;9(suppl):1-5.
7. Bendtzen K. Diamant M, Faber V. Fusidic acid, an immunosuppressive drug with functions similar to cyclosporin A. Cytokine 1990;2:423-9.
8. Nicoletti F, Di Marco R, Morrone S, et al. Reduction of spontaneous autoimmune diabetes in diabetes-prone BB rats with the novel immunosuppressant fusidic acid. Effect on T-cell proliferation and production of interferon-γ. Immunology 1994;81:317-21.
9. Chen Y-L, Le Vraux V, Giroud J-P, et al. Anti-tumor necrosis factor properties of non-peptide drugs in acute-phase responses. Eur J Pharmacol 1994;271:319-27.
10. Nicoletti F, Zaccone P, Di Marco R, et al. Effects of sodium fusidate in animal models of insulin-dependent diabetes mellitus and septic shock. Immunology 1995;85:645-50.
11. Genovese F, Mancuso G, Cuzzola M, et al. Improved survival and antagonistic effect of sodium fusidate on tumor necrosis factor α in a neonatal mouse model of endotoxin shock. Antimicrob Agents Chemother 1996;40: 1733-5.
12. Nicoletti F, Beltrami B, Raschi E, et al. Protection from concanavalin A (Con A)-induced T cell-dependent hepatic lesions and modulation of cytokine release in mice by sodium fusidate. Clin Exp Immunol1997; 110:479-84.
13. Guillain-Barré Syndrome Study Group. Plasmapheresis and acute Guillain-Barré syndrome. Neurology 1985;35:1096-104.
14. Van Der Mechè FGA, Schmitz PIM, and the Ducth Guillain-Barrè study group. A randomized trial comparing intravenous immune globulin and plasma exchange in Guillain-Barrè syndrome. N Engl J Med 1992;326:1123-9.
15. Nicoletti F, Meroni PL, Lunetta M, et al. Sodium fusidate and increased remission rate of insulin-dependent diabetes mellitus. Lancet 1991;337:1292.
16. Buschard K, Pedersen C, Hansen SV, et al. Anti-diabetogenic effect of fusidic acid in diabetes-prone BB rats. Autoimmunity 1992;14:101-4.
17. Langholz E, Brynskov J, Freund LG, et al. Fusidic acid for Bechet's colitis. A novel approach to T-cell specific immunosuppressive therapy. Dan Med Bull 1991;38:284.
18. Langholz E, Brynskov J, Bendtzen K, et al. Treatment of Crohn's disease with fusidic acid: an antibiotic with immunosuppressive properties similar to cyclosporin. Aliment Pharmacol Ther 1992;6:495-502.
19. Bendtzen K, Vesti-Nielsen N, Petersen J, et al. Treatment of chronic endogenous uveitis with fusidic acid. Lancet 1991; 337:552-3.